Currently, the standard approach for treatment of patients with osteosarcoma consists of 10 weeks of preoperative chemotherapy, surgical resection and 20 weeks of postoperative chemotherapy.

Over the past three decades, the prognosis for patients with osteosarcoma has changed dramatically. The development of effective chemotherapy agents has reduced the incidence of metastatic disease ...

Osteosarcoma is a type of bone cancer that originates in the cells that form an individual's bones. In rare cases, it may ...

The data opens the potential for OST-HER2 to be used in frontline therapy in human osteosarcoma prior to initiation of chemotherapy, and potentially reduce the need for chemotherapy altogether ...

In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that ...

Chemotherapy is a treatment for head and neck cancer that uses powerful drugs to attack cancer cells. Often chemotherapy drugs are given before or during radiation to improve the effectiveness of care ...

In search of a treatment regimen that retains tumor control with limited side effects, a team of researchers from the University of Chicago designed a clinical trial to evaluate the response and ...

GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted antibody-drug conjugate (ADC), GSK'227, to treat adults with relapsed or ...

Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...